Significant Ownership of Bain Capital Life Sciences Opportunities III, LP

Signature - Title
/s/ Adam Koppel - Adam Koppel, Partner of Bain Capital Life Sciences Investors, LLC
Location
Boston, MA
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Bain Capital Life Sciences Opportunities III, LP.

Notify me when Bain Capital Life Sciences Opportunities III, LP files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of Bain Capital Life Sciences Opportunities III, LP

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
CABA CABALETTA BIO, INC. Common Stock, $0.00001 par value per share 10% $15,483,400 9,677,125 Bain Capital Life Sciences Opportunities III, LP 30 Jun 2025
KYTX KYVERNA THERAPEUTICS, INC. Common Stock, $0.00001 par value per share 5.4% $25,595,300 3,110,000 Bain Capital Life Sciences Opportunities III, LP 31 Dec 2025
IPSC CENTURY THERAPEUTICS, INC. Common Stock, $0.0001 par value per share 4.1% $1,762,227 3,538,609 Bain Capital Life Sciences Opportunities III, LP 30 Sep 2025
IRON Disc Medicine, Inc. Common Stock, $0.0001 par value per share 3.3% $46,372,025 983,500 Bain Capital Life Sciences Opportunities III, LP 31 Dec 2024

Schedules 13D/G Reported by Bain Capital Life Sciences Opportunities III, LP:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.